Screener
Halozyme Therapeutics HALO Deferred Rent Payments
Deferred Rent Payments at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept halo:DeferredRentPayments.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Accretion of premium on marketable securities, net | (632) | (2,843) |
| Realized loss on marketable securities | 28 | 26 |
| Loss on disposal of equipment | 76 | — |
| Lease payments recognized | 429 | 510 |
| Deferred income taxes | 4,335 | (9,952) |
| Changes in operating assets and liabilities | ||
| Accounts receivable, net and contract assets | (17,385) | (7,884) |
| Inventories | 45,711 | (15,126) |
Item 1. Financial Statements
FAQ
- What is Halozyme Therapeutics's deferred rent payments?
- Halozyme Therapeutics (HALO) reported deferred rent payments of -$215K in Q2 2026.
- How has Halozyme Therapeutics's deferred rent payments changed year-over-year?
- Halozyme Therapeutics's deferred rent payments increased by 16.3% year-over-year, from -$257K to -$215K.
- What is the long-term trend for Halozyme Therapeutics's deferred rent payments?
- Over 4 years (2021 to 2025), Halozyme Therapeutics's deferred rent payments has grown at a 6.1% compound annual growth rate (CAGR), from $751K to -$951K.
- What does deferred rent payments mean?
- This represents the non-cash adjustment for lease obligations where rent payments are spread unevenly over the lease term. It reconciles the difference between the straight-line rent expense recognized in the income statement and the actual cash paid.
Ask your AI about Halozyme Therapeutics's deferred rent payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude